Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Seegene, a biotechnology company, has introduced Seeplex meningitis ACE detection test, reported to be a novel and fast-acting multiplex PCR diagnostic technique to simultaneously verify a complex range of pathogens that indicate meningitis, a severely debilitating infection that if not diagnosed and treated quickly can result in death.
Subscribe to our email newsletter
The Seeplex meningitis ACE detection tests for 12 meningitis-causing pathogens: five bacteria (S pneumoniae, N meningitidis, H influenzae type b, L monocytogenes, and S agalactiae); and seven viruses (HSV1, HSV2, VZV, EBV, CMV, HHV6, and enteroviruses) from cerebrospinal fluid.
Jong-Yoon Chun, founder and CEO of Seegene, said: “Seeplex meningitis ACE detection provides accurate, rapid and cost-effective meningitis diagnostics. The test is a clear break from traditional methods of diagnosing meningitis, taking only six hours to detect either bacterial or viral meningitis infection in an easy to use testing format.
“This test will help to save lives and prevent unnecessary antibiotic prescriptions by providing precise information of meningitis causing pathogens at the earliest possible stage.”